Venus Concept (VERO) Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Venus Concept in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" VERO shares.
View VERO analyst ratings or view top-rated stocks.

Venus Concept's stock was trading at $4.80 at the start of the year. Since then, VERO stock has decreased by 55.6% and is now trading at $2.13.
View the best growth stocks for 2023 here.

Venus Concept saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 55,600 shares, an increase of 104.4% from the April 30th total of 27,200 shares. Based on an average daily volume of 32,600 shares, the days-to-cover ratio is presently 1.7 days. Currently, 2.6% of the shares of the company are sold short.
View Venus Concept's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, August 11th 2023.
View our VERO earnings forecast.

Venus Concept Inc. (NASDAQ:VERO) announced its quarterly earnings data on Monday, May, 15th. The company reported ($1.85) EPS for the quarter. The business earned $20.53 million during the quarter. Venus Concept had a negative trailing twelve-month return on equity of 426.69% and a negative net margin of 47.79%.

Venus Concept's stock reverse split on the morning of Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Venus Concept updated its FY 2023 earnings guidance on Friday, May, 26th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $90.00 million-$95.00 million, compared to the consensus revenue estimate of $91.37 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Venus Concept investors own include Spectrum Pharmaceuticals (SPPI), CONSOL Energy (CEIX), Salesforce (CRM), Cisco Systems (CSCO), SCYNEXIS (SCYX), AzurRx BioPharma (AZRX), Boeing (BA), Interpace Biosciences (IDXG), Johnson & Johnson (JNJ) and Advanced Micro Devices (AMD).

Venus Concept trades on the NASDAQ under the ticker symbol "VERO."

Venus Concept's stock is owned by a variety of retail and institutional investors. Top institutional investors include Commonwealth Equity Services LLC (0.23%). Insiders that own company stock include Anna Georgiadis, Anthony Natale, Chad A Zaring, Domenic Serafino, Healthquest Partners Ii, LP, Keith J Sullivan, Penna Domenic Della, Ross Portaro, Sedco Capital Cayman Ltd, Silva Rajiv De, Stanley Tyler Hollmig and Yoni Iger.
View institutional ownership trends.

Shares of VERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of VERO stock can currently be purchased for approximately $2.13.

Venus Concept (NASDAQ:VERO) has a market capitalization of $11.61 million and generates $99.50 million in revenue each year. The company earns $-43,700,000.00 in net income (profit) each year or ($9.6462) on an earnings per share basis.

The company employs 407 workers across the globe.

Venus Concept's mailing address is 235 YORKLAND BLVD SUITE 900, TORONTO A6, M2J 4Y8. The official website for the company is www.venusconcept.com. The company can be reached via phone at (888) 907-0115 or via email at venusconceptir@westwicke.com.